TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21199978

Group type: EXPERIMENTAL
Intervention: Video Interaction Project (VIP)
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Building Blocks (BB)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 410
Study: 19196106

Group type: COMPARATOR
Intervention: Splinting only
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Splinting plus ultrasound (US)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Splinting plus low-level laser (LLL) therapy
Number of subjects: 50
Study: 16946685

Group type: EXPERIMENTAL
Intervention: Oral estrogen therapy (0.625 mg of conjugated equine estrogens per tablet)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Topical estrogen therapy (0.625 mg conjugated equine estrogens per 1 g vaginal cream)
Number of subjects: 57
Study: 15916107

Group type: EXPERIMENTAL
Intervention: Diet plus exercise
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Standard diet
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 100
Study: 11709448

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 8842586

Group type: EXPERIMENTAL
Intervention: 4 x 1 mg gemeprost every 6 hours (Group I)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 4 x 0.5 mg gemeprost every 6 hours (Group II)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both groups received 5 x 1 mg gemeprost every 3 hours if abortion had not occurred after 24 hours
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Parous women in both groups
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Group II (0.5 mg)
Number of subjects: 100
Study: 1519677

Group type: EXPERIMENTAL
Intervention: Tramadol (642 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Tramadol (0.5, 1.0, and 2.0 mg.kg‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Morphine sulphate (0.143 mg.kg‐1)
Number of subjects: 30
Study: 6546759

Group type: EXPERIMENTAL
Intervention: Modified open meniscectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partial arthroscopic meniscectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional meniscectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Arthroscopic operation
Number of subjects: 0
Study: 30895797

Group type: EXPERIMENTAL
Intervention: l-carnitine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 29038236

Group type: EXPERIMENTAL
Intervention: Prochlorperazine 5 mg, given three times daily for 5 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo, given three times daily for 5 days
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Prochlorperazine
Number of subjects: 120
Study: 26012345

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.25 μg/kg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.38 μg/kg
Number of subjects: 21
Study: 24016037

Group type: EXPERIMENTAL
Intervention: Lidocaine pertubation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 22535759

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation
Number of subjects: 377
Study: 19365139

Group type: EXPERIMENTAL
Intervention: Vitamin D dose decreased
Number of subjects: 345

Group type: COMPARATOR
Intervention: Vitamin D dose increased
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Both vitamin D groups
Number of subjects: 345
Study: 17515459

Group type: EXPERIMENTAL
Intervention: Reminder for use of beta-blockers
Number of subjects: 1271

Group type: COMPARATOR
Intervention: No reminder
Number of subjects: 1271
Study: 15601388

Group type: EXPERIMENTAL
Intervention: Landiolol (0.1 mg/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 11479778

Group type: EXPERIMENTAL
Intervention: Acidum malicum 12 cH
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Acidum ascorbicum 12 cH
Number of subjects: 20
Study: 9533929

Group type: EXPERIMENTAL
Intervention: 50 microg potassium iodide
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: 250 microg potassium iodide
Number of subjects: 126

Group type: COMPARATOR
Intervention: No supplementary iodine (control group)
Number of subjects: 126
Study: 9369918

Group type: EXPERIMENTAL
Intervention: Surgical resection followed by whole brain irradiation (WBI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (SRS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole brain irradiation (WBI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systemic chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consolidating WBI after systemic chemotherapy
Number of subjects: 0
Study: 2663546

Group type: EXPERIMENTAL
Intervention: Femoro-popliteal grafts
Number of subjects: 59

Group type: COMPARATOR
Intervention: Femoro-distal grafts
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Femoro-popliteal group
Number of subjects: 59

Group type: COMPARATOR
Intervention: Femoro-distal group
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 59
Study: 1245147

Group type: COMPARATOR
Intervention: 0.5 g L-dopa
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 0.5 g L-dopa and 1.0 g L-tryptophan
Number of subjects: 13
Study: 30485516

Group type: EXPERIMENTAL
Intervention: Couples calls (CC)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Individual calls (IC)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Diabetes education calls (DE)
Number of subjects: 268
Study: 28222947

Group type: EXPERIMENTAL
Intervention: Arthrocentesis
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Stabilization splint therapy following arthrocentesis
Number of subjects: 120

Group type: COMPARATOR
Intervention: Splint therapy only
Number of subjects: 120
Study: 25264665

Group type: EXPERIMENTAL
Intervention: Endurance followed by Resistance exercise (E + R)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Resistance followed by Endurance exercise (R + E)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (50 minutes rest)
Number of subjects: 19
Study: 23507090

Group type: EXPERIMENTAL
Intervention: Self-reported prescription filling
Number of subjects: 1026
Study: 22674359

Group type: EXPERIMENTAL
Intervention: Early feeding (initiated 48 hours after birth)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Delayed feeding (began on day 5 postpartum)
Number of subjects: 239
Study: 19370371

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (40,000 IU per week)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 16728648

Group type: EXPERIMENTAL
Intervention: LRRK2 G2019S mutation
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: Haplotype analysis
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: Distribution analysis of G2019S
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: Recognition of G2019S
Number of subjects: 586
Study: 15237695

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 101

Group type: COMPARATOR
Intervention: Irbesartan
Number of subjects: 101
Study: 11274308

Group type: EXPERIMENTAL
Intervention: Rapid initiation (900 mg/day immediately following the placebo lead-in)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Slow initiation (300 mg day 1, 600 mg day 2, then 900 mg/day)
Number of subjects: 0
Study: 9249101

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 28

Group type: COMPARATOR
Intervention: C (No epidural anesthesia)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: E + D (Dopamine infusion during epidural anesthesia)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Epidural anesthesia (Group E) vs No epidural anesthesia (Group C)
Number of subjects: 28
Study: 7685682

Group type: EXPERIMENTAL
Intervention: diclofenac/misoprostol 50mg/200 micrograms 2 or 3 times daily
Number of subjects: 4

Group type: COMPARATOR
Intervention: diclofenac 50mg
Number of subjects: 4
Study: 3323368

Group type: EXPERIMENTAL
Intervention: ICRC antileprosy vaccine (0.5 x 10(9) or 1.7 x 10(7) bacilli, intradermally)
Number of subjects: 0
Study: 30089070

Group type: EXPERIMENTAL
Intervention: Labor induction at 39 weeks 0 days to 39 weeks 4 days
Number of subjects: 6106

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 6106
Study: 27821102

Group type: EXPERIMENTAL
Intervention: Health care fund driven program including mobility and falls prevention classes, DXA scan for bone health examination, and consultation about safety in the living environment.
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Health care fund driven program
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Control districts (143 control districts)
Number of subjects: 10000
Study: 25561698

Group type: EXPERIMENTAL
Intervention: SCOPE intervention (home visit, care coordination toolkits, case discussions)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: SCOPE intervention
Number of subjects: 48
Study: 22549879

Group type: EXPERIMENTAL
Intervention: rilonacept 80 mg
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: rilonacept 160 mg
Number of subjects: 241

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 241
Study: 19900209

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with OloGen implant
Number of subjects: 40

Group type: COMPARATOR
Intervention: Trabeculectomy without OloGen implant (control group)
Number of subjects: 40
Study: 18559917

Group type: EXPERIMENTAL
Intervention: AG infusion
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: GnRH (100 microg iv as a bolus)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Naloxone (0.1 mg/kg iv as a slow bolus)
Number of subjects: 7
Study: 15819448

Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 210

Group type: COMPARATOR
Intervention: Cognitive control (rest)
Number of subjects: 210
Study: 12461765

Group type: EXPERIMENTAL
Intervention: Waltz-lessons (dance-learning intervention)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (age-matched depressed patients)
Number of subjects: 10
Study: 10608295

Group type: EXPERIMENTAL
Intervention: Colostrinin (100 microg per tablet, every second day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Commercially available bioorganic selenium (100 microg selenium per tablet, every second day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 46
Study: 7477801

Group type: EXPERIMENTAL
Intervention: Combined cognitive‐behavioral, nutritional and antidepressant therapy (7 with amineptine and 6 with fluoxetine)
Number of subjects: 13
Study: 1951111

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (15, 30, 45, 60, 75, 90, and 105 mg/24 hours)
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (various doses)
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (highest dose)
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 562

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 562
Study: 7028786

Group type: EXPERIMENTAL
Intervention: PGI2 infusion at 0.1 ng/kg per min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PGI2 infusion at 0.4 ng/kg per min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PGI2 infusion at 2.0 ng/kg per min
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (vehicle infusion)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estimated endogenous PGI2 secretion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exogenous PGI2 infusion rates
Number of subjects: 0
Study: 31867648

Group type: EXPERIMENTAL
Intervention: Very low nicotine content (VLNC) cigarettes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal nicotine content control cigarettes
Number of subjects: 0
Study: 28440861

Group type: EXPERIMENTAL
Intervention: Families on Track Integrated Preventive Intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Active control (neuropsychological assessment and personalized community referrals)
Number of subjects: 30
Study: 26422633

Group type: EXPERIMENTAL
Intervention: APACHE III score
Number of subjects: 745
Study: 23932821

Group type: EXPERIMENTAL
Intervention: Earlier-start dialysis
Number of subjects: 208

Group type: COMPARATOR
Intervention: Usual-start dialysis (Control)
Number of subjects: 208
Study: 21251624

Group type: EXPERIMENTAL
Intervention: CYPHER sirolimus-eluting coronary stent (SES)
Number of subjects: 712
Study: 19059391

Group type: EXPERIMENTAL
Intervention: Resistance exercise during long term bed rest (LTBR)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Long term bed rest (LTBR)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Return to initial physical activity after LTBR
Number of subjects: 11
Study: 17184433

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 59
Study: 12959951

Group type: EXPERIMENTAL
Intervention: 300 mg slow-release caffeine (SRC) from recovery day 1 (D1) to D5 (0800)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 5 mg melatonin (Mlt) on preflight D-1 (1700), flight day D0 (1600), and from D1 to D3 (2300)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (Pbo) at the same times as SRC and Mlt
Number of subjects: 27
Study: 12166613

Group type: EXPERIMENTAL
Intervention: Nimesulide (2.9 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diclofenac (3.0 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Celecoxib (12.7 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rofecoxib (3.0 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nimesulide and Diclofenac
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nimesulide (100 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All drugs (Nimesulide, Diclofenac, Celecoxib, Rofecoxib)
Number of subjects: 0
Study: 10189045

Group type: EXPERIMENTAL
Intervention: Low-fat, high-carbohydrate dietary intervention
Number of subjects: 402

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 402
Study: 7865386

Group type: COMPARATOR
Intervention: Iloprost
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy with cyclophosphamide and low-dose corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aminobenzoate potassium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extracorporeal photopheresis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 0
Study: 2744314

Group type: EXPERIMENTAL
Intervention: Mexiletine (200 mg q.i.d.)
Number of subjects: 14
Study: 194524

Group type: EXPERIMENTAL
Intervention: Antibiotic-corticosteroid solution
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Antibiotic-corticosteroid suspension
Number of subjects: 239
Study: 31820541

Group type: EXPERIMENTAL
Intervention: Modified intention-to-treat (ITT) analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Censoring approach
Number of subjects: 0
Study: 30690531

Group type: EXPERIMENTAL
Intervention: Postpartum appointment timing (2-3 weeks after delivery)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Postpartum appointment timing (6-8 weeks after delivery)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Workplace breastfeeding support
Number of subjects: 80

Group type: COMPARATOR
Intervention: Unit and Army support for breastfeeding
Number of subjects: 80
Study: 27611736

Group type: EXPERIMENTAL
Intervention: Pregabalin (150, 300, 600, or 150 to 600 mg/day)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 18
Study: 25954025

Group type: EXPERIMENTAL
Intervention: Violet syrup
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study: 23311498

Group type: EXPERIMENTAL
Intervention: Wide Awake Parenting program (intervention group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study: 21425885

Group type: EXPERIMENTAL
Intervention: Oral indomethacin/prochlorperazine/caffeine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rectal indomethacin/prochlorperazine/caffeine
Number of subjects: 0
Study: 17490753

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) group intervention
Number of subjects: 277

Group type: COMPARATOR
Intervention: Control condition (information booklet)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: CBT group intervention (completers)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Control condition (completers)
Number of subjects: 277
Study: 16460664

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sensodyne
Number of subjects: 40

Group type: COMPARATOR
Intervention: Positive control group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Negative control group
Number of subjects: 40
Study: 12833107

Group type: EXPERIMENTAL
Intervention: High MUFA diet (40% of energy from CHOs, 25% from MUFAs)
Number of subjects: 32

Group type: COMPARATOR
Intervention: High CHO diet (55% of energy from CHOs, 10% from MUFAs)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High MUFA diet
Number of subjects: 32

Group type: COMPARATOR
Intervention: High CHO diet
Number of subjects: 32
Study: 10964199

Group type: COMPARATOR
Intervention: Breast disease pathway
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maternity pathway
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both pathways
Number of subjects: 0
Study: 8784750

Group type: EXPERIMENTAL
Intervention: Endurance training in men (N = 16)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Endurance training in women (N = 9)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Nonaerobic stretching in men (N = 11)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Nonaerobic stretching in women (N = 8)
Number of subjects: 44
Study: 1460211

Group type: COMPARATOR
Intervention: Ipratropium bromide (IB) nasal spray (84 micrograms/nostril, two sprays per nostril, four times a day for 4 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ipratropium bromide (IB) nasal spray
Number of subjects: 0
Study: 6419709

Group type: EXPERIMENTAL
Intervention: XYY men with higher concentrations of testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH)
Number of subjects: 4591

Group type: EXPERIMENTAL
Intervention: XXY men with higher levels of LH, FSH, and prolactin, but low testosterone
Number of subjects: 4591

Group type: COMPARATOR
Intervention: All subjects and XY controls
Number of subjects: 4591

Group type: EXPERIMENTAL
Intervention: Subjects divided into nondelinquents, delinquents without violent convictions, and delinquents with violent convictions
Number of subjects: 4591

Group type: COMPARATOR
Intervention: Psychological interview and projective tests
Number of subjects: 4591

Group type: EXPERIMENTAL
Intervention: XYY men
Number of subjects: 4591
Study: 31158087

Group type: COMPARATOR
Intervention: Docetaxel (75mg/m2) administered alongside standard of care (SOC) hormone therapy for ≥2 years and radiotherapy in some patients.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (SOC) hormone therapy for ≥2 years and radiotherapy in some patients.
Number of subjects: 0
Study: 25924918

Group type: EXPERIMENTAL
Intervention: Olfactory mucosa lamina propria (OLP) transplants (n = 8)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham surgery (control group, n = 4)
Number of subjects: 12
Study: 24989691

Group type: EXPERIMENTAL
Intervention: Self-reported racism
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Sense of control
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Perceived stress
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 365
Study: 22658231

Group type: EXPERIMENTAL
Intervention: Femoral nerve block (group F)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Local anesthetic (group L)
Number of subjects: 55
Study: 20160444

Group type: EXPERIMENTAL
Intervention: Austrian women
Number of subjects: 1074
Study: 18418653

Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic surgery
Number of subjects: 95

Group type: COMPARATOR
Intervention: Straight laparoscopic surgery
Number of subjects: 95
Study: 15852407

Group type: EXPERIMENTAL
Intervention: Once-daily radiotherapy (QDRT)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Twice-daily radiotherapy (BIDRT)
Number of subjects: 263
Study: 12774967

Group type: EXPERIMENTAL
Intervention: Misoprostol 3 microg/kg PO q8h
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Misoprostol 3 microg/kg PO q12h
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: COMPARATOR
Intervention: Aspirin 25 mg/kg PO q8h
Number of subjects: 24
Study: 11071019

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (running)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 9331190

Group type: EXPERIMENTAL
Intervention: Photorefractive keratectomy using the Summit ExciMed UV200LA excimer laser
Number of subjects: 701
Study: 8420491

Group type: EXPERIMENTAL
Intervention: Oral azathioprine (100 to 150 mg/d) in combination with oral prednisolone (1 mg/kg per day)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Four large-volume plasma exchanges in combination with oral prednisolone (1 mg/kg per day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral prednisolone (1 mg/kg per day) alone
Number of subjects: 100
Study: 3541816

Group type: EXPERIMENTAL
Intervention: Milacemide 400 mg b.i.d. (week 1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Milacemide 1,200 mg b.i.d. (week 2)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Milacemide 400 mg (superimposed dosage on day 8)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Milacemide 1,200 mg (superimposed dosage on day 15)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Chronic treatment (1 week and 2 weeks)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Psychometric analyses
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Psychophysiological tests
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pulse rate, systolic and diastolic blood pressure
Number of subjects: 12